Influences of Resting-State Intrinsic Functional Brain Connectivity on the Antidepressant Treatment Response in Late-Life Depression
Supporting Files
-
10-2023
-
File Language:
English
Details
-
Alternative Title:Psychol Med
-
Personal Author:
-
Description:Background:
Late-life depression (LLD) is characterized by differences in resting state functional connectivity within and between intrinsic functional networks. This study examined whether clinical improvement to antidepressant medications is associated with pre-randomization functional connectivity in intrinsic brain networks.
Methods:
Participants were 95 elders aged 60 years or older with major depressive disorder. After clinical assessments and baseline MRI, participants were randomized to escitalopram or placebo with a two-to-one allocation for 8 weeks. Non-remitting participants subsequently entered an 8-week trial of open-label bupropion. The main clinical outcome was depression severity measured by MADRS. Resting state functional connectivity was measured between a priori key seeds in the default mode (DMN), cognitive control, and limbic networks.
Results:
In primary analyses of blinded data, lower post-treatment MADRS score was associated with higher resting connectivity between: a) posterior cingulate cortex (PCC) and left medial prefrontal cortex; b) PCC and subgenual anterior cingulate cortex (ACC); c) right medial PFC and subgenual ACC; d) right orbitofrontal cortex and left hippocampus. Lower post-treatment MADRS was further associated with lower connectivity between: e) the right orbitofrontal cortex and left amygdala; and f) left dorsolateral PFC and left dorsal ACC. Secondary analyses associated mood improvement on escitalopram with anterior DMN hub connectivity. Exploratory analyses of the bupropion open-label trial associated improvement with subgenual ACC, frontal, and amygdala connectivity.
Conclusions:
Response to antidepressants in LLD is related to connectivity in the DMN, cognitive control and limbic networks. Future work should focus on clinical markers of network connectivity informing prognosis.
-
Keywords:
-
Source:Psychol Med. 53(13):6261-6270
-
Pubmed ID:36482694
-
Pubmed Central ID:PMC10250562
-
Document Type:
-
Funding:R01 MH121620/MH/NIMH NIH HHSUnited States/ ; R01 MH102246/MH/NIMH NIH HHSUnited States/ ; UL1TR002243/TR/NCATS NIH HHSUnited States/ ; K24 MH110598/MH/NIMH NIH HHSUnited States/ ; UL1 TR002243/TR/NCATS NIH HHSUnited States/ ; S10 OD021771/OD/NIH HHSUnited States/ ; S10 OD021771/CD/ODCDC CDC HHSUnited States/
-
Volume:53
-
Issue:13
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e295d9d310a703ff0721a970037f90fad34e5737b3443a28a813cff9c0a040f2c8b2970c8853ed9069bab0458780a07a73bb0a47fc9665845442923989aedda5
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access